N-Acetyl Semax
N-acetyl Semax is a modified Semax-like research peptide. N-acetyl Semax, Semax, and vendor products described as N-acetyl Semax amidate are not interchangeable identities. Human dosing, purity standards, exposure, safety, and clinical benefit have not been established.
Pharmacokinetic model
A route-level PK model for n-acetyl semax is being prepared from published data. Dosing references, studies, and documented interactions are below; the app catalog is updated as models are validated.
Key facts
- Category
- Experimental Peptide
- Suggested cadence
- once daily
Research behind this entry
-
The efficacy of Semax in the treatment of patients at different stages of ischemic stroke
This clinical study administered unmodified Semax during stroke rehabilitation and reported BDNF and functional outcomes. It is retained only as indirect parent-analogue context: it supplies no evidence for N-acetyl…
1 published study referenced in the app, each with a plain-language summary.